FLAG regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
Overview
FLAG regimen refers to a regimen consisting of fludarabine, high-dose cytarabine (AraC) and filgrastim (G-CSF), used as a remission-induction treatment for relapsed or refractory childhood acute myeloid leukemia (AML)[1]
Regimen
Regimen
FLFludarabine
ACytarabine (AraC)
GFilgrastim (G-CSF)
References
References
- ↑ 1.0 1.1 Montillo M, Mirto S, Petti MC, Latagliata R, Magrin S, Pinto A; et al. (1998). “Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia”. Am J Hematol. 58 (2): 105–9. PMID 9625576.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH